Stool collection study for cancer patients treated with irinotecan-based therapy
What is the Purpose of this Study?
If you choose to join this study, you will:
- Complete a two-page questionnaire before starting chemotherapy
- Provide a total of four stool (fecal) samples at home
- Provide an optional blood sample in the clinic if you consent
- Report the side effects of standard of care chemotherapy treatment
- Complete a two-page questionnaire before starting chemotherapy
- Provide a total of four stool (fecal) samples at home
- Provide an optional blood sample in the clinic if you consent
- Report the side effects of standard of care chemotherapy treatment
What is the Condition Being Studied?
Colorectal Cancer and Pancreatic Cancer
Who Can Participate in this Study?
Adults with colorectal or pancreatic cancer who:
- Are eligible to receive standard-of-care treatment with any irinotecan-based regimen
- Have not previously received irinotecan treatment
For more information about who can join this study, please contact the study team at sabina.wlazlo@duke.edu.
Age Group
Adults
Participating Institutions
What is Involved?
We are doing this study to see if there is a relationship between specific proteins (found in bacteria in your stool samples) and the chemotherapy side effects that you may experience during standard chemotherapy treatment.
Study Details
Full Title
A STOOL COLLECTION STUDY IN CANCER PATIENTS TREATED WITH IRINOTECAN-BASED REGIMENS
Principal Investigator
Protocol Number
IRB:
PRO00108082
NCT:
NA
ClinicalTrials.gov
View on ClinicalTrials.gov